Chris Robillard
Corporate Officer/Principal en CRINETICS PHARMACEUTICALS, INC. .
Perfil
Chris Robillard is currently the Chief Business Officer at Crinetics Pharmaceuticals, Inc. He previously worked as the Vice President & Head of Business Development at Goldfinch Bio, Inc. and as the Head of Business Development & Corporate Strategy at Karyopharm Therapeutics, Inc. Mr. Robillard completed his undergraduate degree at Lehigh University and holds an MBA from Pepperdine University.
Cargos activos de Chris Robillard
| Empresas | Cargo | Inicio |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 21/03/2022 |
Antiguos cargos conocidos de Chris Robillard.
| Empresas | Cargo | Fin |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - |
Goldfinch Bio, Inc.
 Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formación de Chris Robillard.
| Lehigh University | Undergraduate Degree |
| Pepperdine University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Chris Robillard
